Targeted Protein Degradation Market: By Modality (PROTACs/Bifunctional Degraders, Molecular Glues, Other [LYTACs, AUTACs]); Target Protein (Transcription Factors, Kinases, Nuclear Receptors, Scaffolding Proteins); Indication (Oncology, Immunology & Inflammation, Neurodegeneration, Others); Development Stage (Preclinical, Clinical, Approved); End User (Biopharma, Academic & Research, CROs)— Market Size, Industry Dynamics, Opportunity Analysis and Forecast For 2026–2035
The targeted protein degradation market is estimated at USD 690.8 million in 2025 and is projected to reach USD 5,004.9 million by 2035, growing at a CAGR of 21.9% over the forecast period 2026–2035. Read More
We Are Trusted By These Great Companies!
Last Updated: 15-Jul-2026 | Format: | Report ID: AA07261884